HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabelle Schrauwen Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2020ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer's disease.
1/2020Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease.
1/2017Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabelle Schrauwen Research Topics

Disease

16Hearing Loss (Hearing Impairment)
10/2020 - 09/2007
14Otosclerosis
04/2022 - 07/2007
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2017
2Bicuspid Aortic Valve Disease
10/2021 - 10/2021
2Nonsyndromic Deafness
01/2019 - 01/2016
2Microcephaly
09/2018 - 01/2015
2Conductive Hearing Loss
09/2010 - 07/2007
1Fundus Albipunctatus
02/2022
1Gaucher Disease (Gaucher's Disease)
01/2022
1Left Ventricular Dysfunction
11/2021
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
08/2020
1Paraplegia (Spastic Paraplegia)
01/2020
1Multiple Abnormalities
01/2019
1Bone Resorption
01/2019
1Intellectual Disability (Idiocy)
09/2018
1Autosomal Recessive Deafness
01/2017
1Infantile Epileptic-Dyskinetic Encephalopathy
01/2017
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2017
1Brain Diseases (Brain Disorder)
01/2016
1Osteosarcoma (Osteogenic Sarcoma)
03/2014
1Sensorineural Hearing Loss
09/2011
1type 1 Stickler syndrome
07/2011
1Measles
06/2010

Drug/Important Bio-Agent (IBA)

12Capsules (Microcapsules)IBA
08/2019 - 07/2007
6DNA (Deoxyribonucleic Acid)IBA
10/2020 - 03/2009
3RNA (Ribonucleic Acid)IBA
01/2020 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2017
2TungstenIBA
10/2021 - 10/2021
2Nonsense Codon (Nonsense Mutation)IBA
01/2019 - 01/2015
2Carrier Proteins (Binding Protein)IBA
01/2017 - 10/2012
2Transforming Growth Factor beta (TGF-beta)IBA
04/2008 - 09/2007
1Aggrecans (Aggrecan)IBA
04/2022
1Retinal DehydrogenaseIBA
02/2022
1SaposinsIBA
01/2022
1Glucosylceramidase (Glucocerebrosidase)IBA
01/2022
1Fibrillin-1IBA
11/2021
1Transaminases (Aminotransferases)IBA
08/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
15' Untranslated Regions (5' UTR)IBA
08/2019
13' Untranslated Regions (3' UTR)IBA
08/2019
1Initiator Codon (Start Codon)IBA
01/2019
1Aspartic Acid (Aspartate)FDA Link
01/2019
1Serine (L-Serine)FDA Link
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016
1Conditioned Culture MediaIBA
03/2014
1A-Form DNA (A-DNA)IBA
01/2013
1NucleotidesIBA
07/2011
1FluoridesIBA
06/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2010
1Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2009
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
04/2008
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2007
1CollagenIBA
07/2007
1alpha2 Subunit Collagen Type IIBA
07/2007